Repro Med Systems, Inc. (KRMD)
| Previous Close | 3.4400 |
| Open | 3.5100 |
| Bid | 3.2500 x 1000 |
| Ask | 3.3700 x 1100 |
| Day's Range | 3.2500 - 3.6668 |
| 52 Week Range | 2.3000 - 6.5000 |
| Volume | |
| Avg. Volume | 163,744 |
| Market Cap | 148.548M |
| Beta (5Y Monthly) | 0.47 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Business Wire
KORU Medical Systems to Unveil Updated Strategic Plan at Investor Day
CHESTER, N.Y., December 01, 2021--Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development of innovative and easy-to-use home infusion solutions, today announced it will host an investor day to provide an update to its strategic plan.
- Business Wire
KORU Medical Announces FDA Clearance for Delivery of Hizentra® Prefilled Syringes
CHESTER, N.Y., November 10, 2021--Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use specialty infusion solutions that improve quality of life for patients, today announced 510k clearance for use of the KORU Medical FreedomEdge® infusion pump to deliver Hizentra® [immune globulin subcutaneous (human) 20% liquid] 20 mL
- Business Wire
KORU Medical Systems to Participate in Two Upcoming Conferences
CHESTER, N.Y., November 09, 2021--Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development of innovative and easy-to-use home infusion solutions, today announced its participation in two upcoming conferences, Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum and the 33rd Annual Piper Sandler Healthcare Conference.
